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patients in each group did not take up treatment, 2 refused family therapy and were given individual therapy instead, 29 attended the minimum adequate treatment (at least 4 sessions) of family therapy, and 31 attended at least 4 sessions of guided self-care. The authors noted that the proportion of patients attending 4 or more sessions was similar in the two treatment groups.
Study design
The study was a multi-centre, randomised controlled trial that was carried out in four eating disorder services. Randomisation was conducted using permutated blocks of random sizes between 4 and 10. Randomisation was undertaken using a computerised randomisation database. Allocation was concealed until the interventions were assigned. Blinding of the patients and clinicians does not appear to have been possible. However, the research assistant performing the 6-and 12-month assessments was blind to treatment assignment. Recruitment to the trial took place between September 2000 and May 2003, and the patients were followed-up at 6 and 12 months. The proportion of patients who did not complete any of the 6-or 12-month follow-up measures was 4.9% in the family therapy group and 15.9% in the guided self-care group.
Analysis of effectiveness
The primary outcome variables were abstinence rates from binging and vomiting over the previous month, assessed at 6 and 12 months on the EATATE interview. Binging and vomiting rates were defined as "abstinence" (behaviour absent during the previous 28 days), "subclinical" (behaviour present during previous 28 days less than twice per week), and "clinical" (behaviour present during previous 28 days two or more times per week). Other outcomes included the same abstinence rates assessed on the Short Evaluation of Eating Disorders, longitudinal assessment of binging and vomiting by interview at baseline and at 2, 4, 6, 8 and 10 months, and other eating disorder symptoms. The analysis was conducted on an intention to treat principle. The two groups of patients were comparable in terms of their baseline sociodemographic and clinical characteristics. The authors also analysed the results after adjusting for antidepressant use at baseline.
Effectiveness results
It was reported that a significantly higher proportion of patients in the guided self-care group were abstinent from binging at 6 months compared with the family therapy group, 0.42 (95% confidence interval, CI: 0.26 to 0.59) versus 0.25 (95% CI: 0.13 to 0.42).
There were no statistically significant differences between the two groups in binging at 12 months and in vomiting at 6 and 12 months. The results did not change after adjusting for antidepressant use at baseline.
Outcomes on the Short Evaluation of Eating Disorders were comparable to those obtained through EATATE interview.
Longitudinal assessment showed significant improvement with time for binging, (F=6.96, df=6, p<0.0001) and vomiting, (F=2.39, df=6, p<0.02).
There were no other differences between the groups in other eating disorder outcomes.
Clinical conclusions

Synthesis of costs and benefits
There was no synthesis of the costs and benefits as this was a cost-consequences study.
Authors' conclusions
In adolescents with bulimia nervosa or eating disorder not otherwise specified, guided self-care had a slight advantage over family therapy in terms of acceptability, outcome and treatment cost. Overall, the "cost and outcome findings suggest a cost-effectiveness advantage to guided self-care".
CRD COMMENTARY -Selection of comparators
A justification was provided for the technologies compared. Family-based treatment seems to have been standard practice for adolescents with bulimia nervosa in the authors' setting. The authors noted that CBT-guided self-care could be as effective as therapist-delivered CBT, which was considered common practice for adults with bulimia nervosa. The merit of CBT-guided self-care relative to family therapy in adolescents was unknown. You should decide if these represent valid comparators in your own setting.
Validity of estimate of measure of effectiveness
The analysis was based on a randomised controlled trial. The study sample was representative of the study population. The fact that the study was carried out in eating disorder services, which are the main service providers for the populations, may provide the reader with some reassurance that the sample was typical of the study population. In addition, the patient groups were shown to be comparable at analysis. The method of randomisation, length of study and loss to follow-up were all reported, which suggests that the internal validity of the study is likely to be good. Given the nature of the intervention, blinding was only possible for the research assistants responsible for the assessments. Appropriate statistical analyses were undertaken to take account of potential biases (intention to treat, CIs and p-values reported) and confounding factors (adjustment for antidepressant use at baseline). Power calculations were reported to ensure that the size of the study sample was adequate.
Validity of estimate of measure of benefit
The authors did not derive a summary measure of benefit. In effect, a cost-consequences analysis was performed.
Validity of estimate of costs
The authors did not explicitly state the perspective of their study, but it appears to have been societal. All the relevant categories of costs and costs within each category seem to have been included in the analysis. The resource quantities were collected alongside the trial but were not presented. The source of the unit costs was presented (national data) but not the unit costs themselves, as the authors presented only average costs. Discounting was not necessary given that the time horizon for the estimation of the costs was one year. The authors evaluated uncertainty in the cost data by bootstrapping the significant differences in costs between the two treatment groups. The cost data were not reported adequately, as there was no reference to the price year or resource dates and the unit costs and resource quantities were not reported separately. There was no sensitivity analysis to address variation in the unit costs or service provision for different settings. The fact that the cost data were poorly reported may have implications for the generalisability of the study beyond the study setting Other issues
